Cerebral insulin resistance is an important and targetable causal component in the pathogenesis of AD and targeting this pathway is a promising therapeutic strategy, however, challenges such as standardization of measurement, rigorous trial design, and crossing the blood-brain barrier require attention before widesprea...
Sam Torabi Goodarzi, Issa Layali, Zahra Nematollah· Medical Sciences Journal of...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.